Omada Health, Inc.
OMDA
$22.14
$0.180.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 48.92% | 56.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 48.92% | 56.61% | |||
| Cost of Revenue | 28.62% | 29.95% | |||
| Gross Profit | 62.30% | 83.88% | |||
| SG&A Expenses | 33.77% | 19.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 28.23% | 19.35% | |||
| Operating Income | 56.72% | 53.34% | |||
| Income Before Tax | 50.33% | 50.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 50.33% | 50.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 50.33% | 50.19% | |||
| EBIT | 56.72% | 53.34% | |||
| EBITDA | 66.25% | 58.13% | |||
| EPS Basic | 82.71% | 54.71% | |||
| Normalized Basic EPS | 82.70% | 54.71% | |||
| EPS Diluted | 82.71% | 54.71% | |||
| Normalized Diluted EPS | 82.70% | 54.71% | |||
| Average Basic Shares Outstanding | 187.24% | 9.98% | |||
| Average Diluted Shares Outstanding | 187.24% | 9.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||